Orbimed Advisors and Power Corporation backed BELLUS Health (NASDAQ/TSX: BLU) completed US $70M public offering in Canada and US and traded on NASDAQRead More →
My Intelligences Machines (MIMS) secured $2.6M seed funding from members of Anges Québec, Anges Québec Capital, Desjardins Capital, Consortium MEDTEQ, Real Ventures, StandUp Ventures.Read More →
Repare Therapeutics secured US $82.5M Series B from Cowen Healthcare Investments, OrbiMed, Redmile, BVF Partners, Logos Capital, Versant Ventures, MPM Capital, Fonds de solidarité, BDC CapitalRead More →
OrbiMed, Power Corporation backed BELLUS Health filed for US $60M public offering and listing of its common shares on Nasdaq Global Market (NASDAQ) Read More →
ESSA Pharma closed US $36M public offering and private placement led by Soleus Capital with participation of RA Capital Management, BVF Partners, Omega Funds, Eventide Funds Read More →
Chinook Therapeutics secured US $65M Series A funding led by Versant Ventures with participation of seed investor Apple Tree Partners and new investor Samsara BioCapital.
Read More →
R.C. Morris Capital Management Ltd. provided $25M senior secured debt to Zenabis Global Inc. (TSX: ZENA) Read More →
iGan Partners backed MolecuLight secured US $7.5M term loan from Oxford Finance LLCRead More →
Caisse de dépôt et placement du Québec (CDPQ) invested US $500M in Sanfer, joining General Atlantic as minority shareholdersRead More →
Tevosol raised $2 million in additional seed funding, bringing total seed funding to $6.3 million to date since 2016.Read More →
Stryker (NYSE: SYK) proposes to acquire TSO3 (TSX: TOS) from Caisse de dépôt et placement du Québec (CDPQ) and other shareholders for CDN $68.4M including existing indebtedness.Read More →
Bayer to acquire the remaining 59.2% stake in BlueRock Therapeutics from Versant Ventures for up to US $600 million Read More →
